The objective of the present study is to investigate the cardioprotective role of DFO in newly diagnosed pediatric cancer patients treated with DXO using echocardiography and serum markers such as N-terminal pro-brain natriuretic peptide (NT-proBNP) and cardiac troponin I (cTnI). The gene discussed is TNNI3; the disease is cancer.